These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6801270)

  • 1. Unanticipated vesicoureteral reflux: a possible sequela of long-term thio-tepa instillations to the bladder.
    Mukamel E; Glanz I; Nissenkorn I; Cytron S; Servadio C
    J Urol; 1982 Feb; 127(2):245-6. PubMed ID: 6801270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux.
    Nissenkorn I; Servadio C; Vilikowski E; Glanz I
    J Urol; 1985 Feb; 133(2):198-9. PubMed ID: 3918177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The harmfulness of intravesical instillations of thiotepa in cases of vesico-renal reflux].
    Rampal M; Alimi JC; Pons G; Fiquet JM
    J Urol Nephrol (Paris); 1978 Mar; 84(3):271-4. PubMed ID: 417193
    [No Abstract]   [Full Text] [Related]  

  • 4. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma.
    Brosman SA
    J Urol; 1982 Jul; 128(1):27-30. PubMed ID: 6809960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicorenal reflux and upper urinary tract transitional cell carcinoma after transurethral resection of recurrent superficial bladder carcinoma.
    De Torres Mateos JA; Banús Gassol JM; Palou Redorta J; Morote Robles J
    J Urol; 1987 Jul; 138(1):49-51. PubMed ID: 3599219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vesicoureteral reflux in recurrent carcinoma of the bladder--implications for treatment and prognosis.
    Schmidt JD; Jacobo EC; Weinstein SH
    J Urol; 1976 Dec; 116(6):734-6. PubMed ID: 826656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A longitudinal study of patients with superficial bladder carcinoma successfully treated with weekly intravesical thio-tepa.
    Nocks BN; Nieh PT; Prout GR
    J Urol; 1979 Jul; 122(1):27-9. PubMed ID: 110947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicoureteral reflux following transurethral resection of bladder tumors.
    Freed SZ
    J Urol; 1976 Aug; 116(2):184-7. PubMed ID: 950700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper urinary tract transitional cell carcinoma in patients with bladder carcinoma and associated vesicoureteral reflux.
    Amar AD; Das S
    J Urol; 1985 Mar; 133(3):468-71. PubMed ID: 3973999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic effect of triethylenethiophosphoramide on the recurrence rate of superficial bladder tumors.
    Mukamel E; Zitron S; Nissenkorn I; Servadio C
    Isr J Med Sci; 1980; 16(9-10):714-6. PubMed ID: 6776072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histopathological study of secondary ureteral tumors occurring in 4 cases of bladder tumors].
    Mishina T
    Hinyokika Kiyo; 1987 Aug; 33(8):1172-9. PubMed ID: 3425517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper tract tumours in patients with vesico-ureteral reflux and recurrent bladder tumours.
    Mukamel E; Nissenkorn I; Glanz I; Vilcovsky E; Servadio C
    Eur Urol; 1985; 11(1):6-8. PubMed ID: 3987750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of intravesical bacillus Calmette-Guerin therapy on the upper urinary tract.
    Mukamel E; Vilkovsky E; Hadar H; Engelstein D; Nussbaum B; Servadio C
    J Urol; 1991 Oct; 146(4):980-1. PubMed ID: 1895455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravesical thio-tepa on normal and tumor urothelium.
    Nieh PT; Daly JJ; Heaney JA; Heney NM; Prout GR
    J Urol; 1978 Jan; 119(1):59-61. PubMed ID: 413937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of cystography in thio-tepa toxicity.
    Orlin I
    J Urol; 1972 Aug; 108(2):257-8. PubMed ID: 4625850
    [No Abstract]   [Full Text] [Related]  

  • 16. Vesicoureteral reflux following transurethral resection of bladder tumours at the ureteral orifice.
    Kisbenedek L; Szeldeli P; Biró G; Balogh F
    Eur Urol; 1982; 8(1):9-10. PubMed ID: 7060613
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of superficial papillary transitional cell carcinoma of the ureter by vesicoureteral reflux of mitomycin C.
    Smith AY; Vitale PJ; Lowe BA; Woodside JR
    J Urol; 1987 Nov; 138(5):1231-3. PubMed ID: 3118057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prophylactic use of thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.
    Hisazumi H; Uchibayashi T; Naito K; Misaki T; Miyazaki K
    J Urol; 1975 Sep; 114(3):394-8. PubMed ID: 806708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical thio-tepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder.
    Gavrell GJ; Lewis RW; Meehan WL; Leblanc GA
    J Urol; 1978 Oct; 120(4):410-1. PubMed ID: 100615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usual harmlessness of endovesical instillations of thio-tepa].
    des Roseaux M; Vacant J; Beurton D; Cukier J
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):485-7. PubMed ID: 4216647
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.